Oasmia Pharmaceutical AB PE Ratio 2015-2018 | OASM

Current and historical p/e ratio for Oasmia Pharmaceutical AB (OASM) from 2015 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Oasmia Pharmaceutical AB PE ratio as of December 14, 2018 is 0.00.
Oasmia Pharmaceutical AB PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-12-14 3.45 0.00
2018-10-31 3.95 $-0.13 0.00
2018-06-30 1.32 $-0.18 0.00
2018-04-30 1.63 $-0.27 0.00
2018-01-31 1.44 $-0.32 0.00
2017-10-31 0.98 $-0.37 0.00
2017-07-31 0.98 $-0.46 0.00
2017-04-30 2.11 $-0.49 0.00
2017-01-31 2.79 $-0.48 0.00
2016-10-31 3.37 $-0.45 0.00
2016-07-31 3.18 $-0.36 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.145B $0.000B
Oasmia Pharmaceutical AB is a pharmaceutical company which develops and manufactures drugs for human and veterinary oncology. Its drugs portfolio comprises Paclical, Doxophos, Docecal and OAS-19, for human treatment as well as Paccal Vet-CA1 and Doxophos Vet, for cancer treatment in dogs, which are in different clinical phases. Oasmia Pharmaceutical AB is based in Uppsala, Sweden.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.409B 11.39
Zoetis (ZTS) United States $42.496B 29.09
Grifols (GRFS) Spain $12.892B 15.73
Jazz Pharmaceuticals (JAZZ) Ireland $8.479B 12.17
Ionis Pharmaceuticals (IONS) United States $7.282B 0.00
Tilray (TLRY) United States $6.999B 0.00
Neurocrine Biosciences (NBIX) United States $6.469B 1426.80
Nektar Therapeutics (NKTR) United States $6.319B 9.06
Catalent (CTLT) United States $5.036B 21.12
Impax Laboratories (AMRX) United States $4.810B 0.00
Sage Therapeutics (SAGE) United States $4.782B 0.00
United Therapeutics (UTHR) United States $4.703B 7.69
Loxo Oncology (LOXO) United States $4.251B 0.00
TESARO (TSRO) United States $4.056B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.483B 12.90
FibroGen (FGEN) United States $3.361B 0.00
USANA Health Sciences (USNA) United States $2.895B 24.64
Endo (ENDP) Ireland $2.286B 3.50
Xencor (XNCR) United States $2.031B 0.00
Endocyte (ECYT) United States $1.957B 0.00
Heron Therapeutics (HRTX) United States $1.948B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.861B 251.44
Corcept Therapeutics (CORT) United States $1.860B 27.31
Ironwood Pharmaceuticals (IRWD) United States $1.810B 0.00
Zogenix (ZGNX) United States $1.739B 0.00
Aerie Pharmaceuticals (AERI) United States $1.737B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.697B 0.00
PTC Therapeutics (PTCT) United States $1.697B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.463B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.433B 20.15
Tricida (TCDA) United States $1.340B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.321B 0.00
Esperion Therapeutics (ESPR) United States $1.286B 0.00
Portola Pharmaceuticals (PTLA) United States $1.252B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.238B 0.00
TherapeuticsMD (TXMD) United States $0.921B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.906B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.807B 0.00
ImmunoGen (IMGN) United States $0.772B 0.00
Radius Health (RDUS) United States $0.719B 0.00
Forty Seven (FTSV) United States $0.712B 0.00
Collegium Pharmaceutical (COLL) United States $0.603B 0.00
Karyopharm Therapeutics (KPTI) United States $0.584B 0.00
Siga Technologies (SIGA) United States $0.558B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.513B 0.00
ChemoCentryx (CCXI) United States $0.507B 40.12
Flexion Therapeutics (FLXN) United States $0.505B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.446B 26.29
GlycoMimetics (GLYC) United States $0.446B 0.00
Akebia Therapeutics (AKBA) United States $0.435B 0.00
Xeris Pharmaceuticals (XERS) United States $0.420B 0.00
Dova Pharmaceuticals (DOVA) United States $0.418B 0.00
Dermira (DERM) United States $0.417B 0.00
Odonate Therapeutics (ODT) United States $0.406B 0.00
CASI Pharmaceuticals (CASI) United States $0.405B 0.00
Tyme Technologies (TYME) United States $0.398B 0.00
KalVista Pharmaceuticals (KALV) United States $0.390B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
Translate Bio (TBIO) United States $0.370B 0.00
ArQule (ARQL) United States $0.351B 0.00
OptiNose (OPTN) United States $0.340B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.336B 0.00
Majesco Entertainment (PTE) United States $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.316B 0.00
Tapimmune (MRKR) United States $0.309B 0.00
Minerva Neurosciences (NERV) United States $0.305B 0.00
Aclaris Therapeutics (ACRS) United States $0.299B 0.00
Aratana Therapeutics (PETX) United States $0.299B 0.00
Mast Therapeutics (SVRA) United States $0.261B 0.00
Depomed (ASRT) United States $0.259B 9.64
Verrica Pharmaceuticals (VRCA) United States $0.258B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
IMV INC (IMV) Canada $0.245B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.240B 0.00
Ocular Therapeutix (OCUL) United States $0.219B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.216B 0.00
Affimed (AFMD) Germany $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.205B 0.00
Zafgen (ZFGN) United States $0.191B 0.00
Lannett Co Inc (LCI) United States $0.190B 1.65
TAIWAN LIPOSOME (TLC) Taiwan $0.188B 0.00
Aquestive Therapeutics (AQST) United States $0.184B 0.00
MEI Pharma (MEIP) United States $0.180B 0.00
Calithera Biosciences (CALA) United States $0.175B 0.00
Opexa Therapeutics (ACER) United States $0.174B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.172B 0.00
Molecular Templates (MTEM) United States $0.166B 0.00
ContraFect (CFRX) United States $0.165B 0.00
Recro Pharma (REPH) United States $0.164B 0.00
Nature's Sunshine Products (NATR) United States $0.162B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.159B 0.00
Neon Therapeutics (NTGN) United States $0.158B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.147B 0.00
Redhill Biopharma (RDHL) Israel $0.145B 0.00
Ardelyx (ARDX) United States $0.134B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.133B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.132B 0.00
MediWound (MDWD) Israel $0.130B 0.00
Cardiome Pharma (CORV) Canada $0.129B 0.00
ElectroCore (ECOR) United States $0.120B 0.00
Adherex Technologies (FENC) United States $0.117B 0.00
Jounce Therapeutics (JNCE) United States $0.115B 0.00
DURECT (DRRX) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
ProNAi Therapeutics (SRRA) Canada $0.104B 0.00
Iterum Therapeutics (ITRM) Ireland $0.102B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.093B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.091B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.081B 0.00
Immune Design (IMDZ) United States $0.076B 0.00
Achaogen (AKAO) United States $0.075B 0.00
Natural Alternatives (NAII) United States $0.075B 7.36
CTI BioPharma (CTIC) United States $0.072B 0.00
Otonomy (OTIC) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Melinta Therapeutics (MLNT) United States $0.066B 0.00
BioLineRx (BLRX) Israel $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.062B 0.00
KemPharm (KMPH) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Avenue Therapeutics (ATXI) United States $0.056B 0.00
Genocea Biosciences (GNCA) United States $0.048B 0.00
Mannatechorporated (MTEX) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
ProPhase Labs (PRPH) United States $0.036B 0.00
Capnia (SLNO) United States $0.035B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
Novan (NOVN) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
Lipocine (LPCN) United States $0.030B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
Trillium Therapeutics (TRIL) Canada $0.027B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
SCYNEXIS (SCYX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.020B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
PharmAthene (ALT) United States $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
Onconova Therapeutics (ONTX) United States $0.018B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.05
ESSA Pharma (EPIX) Canada $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.014B 0.00
Shineco (TYHT) China $0.013B 1.40
Regulus Therapeutics (RGLS) United States $0.012B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Skyline Medical (AIPT) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Aradigm (ARDM) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00